Product

Sogacin/TOCScan - Gallium (⁶⁸Ga) edotreotide

Marketing Authorizations

Country
Product Name
MA number
Date of registration
PDF
France
Sogacin
3400955023692
01.07.2016
Austria
Sogacin
437334
7.12.2016
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
Germany
TOCscan
98351.00.00
09.12.2016
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found

Sogacin/TOCscan is used for imaging in patients undergoing oncologic diagnostic procedures describing functions or diseases where enhanced somatostatin receptors expression of specific organs or tissues is the diagnostic target.

Sogacin/TOCscan binds specifically to somatostatin receptors.

Sogacin/TOCscan is indicated for use with positron emission tomography (PET).

The following indications have been particularly documented:

  • Detection of the primary occult neuroendocrine tumour when a metastasis of neuroendocrine tumour has been demonstrated or when the serum concentration of a specific marker is increased,
  • Characterisation of bronchial mass as neuroendocrine tumour when other diagnostic modalities have not been conclusive,
  • Characterisation, initial staging, detection in case of biochemical recurrence and restaging of neuroendocrine tumours of the foregut, including in the thymus or the bronchi,
  • Characterisation, initial staging, detection in case of biochemical recurrence and restaging of neuroendocrine tumours of the midgut, when 6-fluoro-(18F)-L-dihydroxyphenylalanine is not available or when PET with 6-fluoro-(18F)-L-dihydroxyphenylalanine is non-conclusive,
  • As an adjunct to anatomic imaging in pre-therapeutic evaluation of meningeoma.

Tumours which do not bear somatostatin receptors will not be visualised with Sogacin/TOCscan.

Therapeutic indications. This medicinal product is for diagnostic use only.

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Find out more about Curium’s global footprint

Scroll to Top
Iason Logo Alt
curium logo

Welcome to our new website

You've been redirected from iason.eu to our new domain curium-austria.com

Curium acquired IASON in June of 2021, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions. Learn more on Curium’s website